CytomX Therapeutics Inc (CTMX) — Capital Reinvestment Ratio
CytomX Therapeutics Inc (CTMX) has a Capital Reinvestment Ratio of 0.01x as of March 2023, meaning it reinvests 0% of its operating cash flow ($9.35 Million) in capital expenditures ($48.00K). Check CytomX Therapeutics Inc (CTMX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CytomX Therapeutics Inc Capital Reinvestment Ratio (2014–2020)
This chart tracks CytomX Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see CytomX Therapeutics Inc cash flow conversion.
Annual Capital Reinvestment Ratio for CytomX Therapeutics Inc (2014–2020)
Year-by-year Capital Reinvestment Ratio for CytomX Therapeutics Inc from 2014 to 2020. See CytomX Therapeutics Inc (CTMX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.44x | $5.26 Million | $2.31 Million | ▲ +4698.2% |
| 2017 | 0.01x | $170.37 Million | $1.56 Million | ▼ -82.5% |
| 2014 | 0.05x | $31.80 Million | $1.66 Million | — |